Document is current
Any future updates will be listed below
-
Authors
Jover Cerdá, Vicente https://orcid.org/0000-0002-2602-4532
Rodríguez Pacheco, Ramón
Doménech Witek, Joan
Alonso Hernández, Sonia
Durán García, Rafael
Real Panisello, Marina
Marco de la Calle, Francisco Manuel
- License Information
-
More Information
Article History
Received: 27 January 2022
Accepted: 8 May 2022
First Online: 27 May 2022
Declarations
:
: The Drug Research Ethics Committee of the General University Hospital of Elda (Alicante, Spain) approved the study on November 26, 2021, with the protocol code VACUNALGUEÑA, VERSION 2. Patients were informed about the details of the study for which they gave their consent to participate, according to recently published clinical practice.
: Patients were informed that the results of the study were going to be published and gave their consent.
: The authors declare that they have no competing interests.
